Global and United States Pulmonary Arterial Hypertension (PAH) Market Report & Forecast 2022-2028

Global and United States Pulmonary Arterial Hypertension (PAH) Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Pulmonary Arterial Hypertension (PAH) Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022) & (US$ Million) Introduction
1.2 Global Pulmonary Arterial Hypertension (PAH) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pulmonary Arterial Hypertension (PAH) Market Size for the Year 2017-2028
1.2.2 Global Pulmonary Arterial Hypertension (PAH) Market Size for the Year 2017-2028
1.3 Pulmonary Arterial Hypertension (PAH) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Pulmonary Arterial Hypertension (PAH) in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Pulmonary Arterial Hypertension (PAH) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Pulmonary Arterial Hypertension (PAH) Market Dynamics
1.4.1 Pulmonary Arterial Hypertension (PAH) Industry Trends
1.4.2 Pulmonary Arterial Hypertension (PAH) Market Drivers
1.4.3 Pulmonary Arterial Hypertension (PAH) Market Challenges
1.4.4 Pulmonary Arterial Hypertension (PAH) Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Pulmonary Arterial Hypertension (PAH) by Type
2.1 Pulmonary Arterial Hypertension (PAH) Market Segment by Type
2.1.1 Prostacyclin and Prostacyclin Analogs
2.1.2 SGC Stimulators
2.1.3 ERA
2.1.4 PDE-5
2.2 Global Pulmonary Arterial Hypertension (PAH) Market Size by Type (2017, 2022 & 2028)
2.3 Global Pulmonary Arterial Hypertension (PAH) Market Size by Type (2017-2028)
2.4 United States Pulmonary Arterial Hypertension (PAH) Market Size by Type (2017, 2022 & 2028)
2.5 United States Pulmonary Arterial Hypertension (PAH) Market Size by Type (2017-2028)
3 Pulmonary Arterial Hypertension (PAH) by Application
3.1 Pulmonary Arterial Hypertension (PAH) Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.2 Global Pulmonary Arterial Hypertension (PAH) Market Size by Application (2017, 2022 & 2028)
3.3 Global Pulmonary Arterial Hypertension (PAH) Market Size by Application (2017-2028)
3.4 United States Pulmonary Arterial Hypertension (PAH) Market Size by Application (2017, 2022 & 2028)
3.5 United States Pulmonary Arterial Hypertension (PAH) Market Size by Application (2017-2028)
4 Global Pulmonary Arterial Hypertension (PAH) Competitor Landscape by Company
4.1 Global Pulmonary Arterial Hypertension (PAH) Market Size by Company
4.1.1 Top Global Pulmonary Arterial Hypertension (PAH) Companies Ranked by Revenue (2021)
4.1.2 Global Pulmonary Arterial Hypertension (PAH) Revenue by Player (2017-2022)
4.2 Global Pulmonary Arterial Hypertension (PAH) Concentration Ratio (CR)
4.2.1 Pulmonary Arterial Hypertension (PAH) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Pulmonary Arterial Hypertension (PAH) in 2021
4.2.3 Global Pulmonary Arterial Hypertension (PAH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pulmonary Arterial Hypertension (PAH) Headquarters, Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022) & (US$ Million) Type
4.3.1 Global Pulmonary Arterial Hypertension (PAH) Headquarters and Area Served
4.3.2 Global Pulmonary Arterial Hypertension (PAH) Companies Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Pulmonary Arterial Hypertension (PAH) Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Pulmonary Arterial Hypertension (PAH) Market Size by Company
4.5.1 Top Pulmonary Arterial Hypertension (PAH) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pulmonary Arterial Hypertension (PAH) Revenue by Players (2020, 2021 & 2022)
5 Global Pulmonary Arterial Hypertension (PAH) Market Size by Region
5.1 Global Pulmonary Arterial Hypertension (PAH) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pulmonary Arterial Hypertension (PAH) Market Size by Region (2017-2028)
5.2.1 Global Pulmonary Arterial Hypertension (PAH) Market Size by Region: 2017-2022
5.2.2 Global Pulmonary Arterial Hypertension (PAH) Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth 2017-2028
6.1.2 North America Pulmonary Arterial Hypertension (PAH) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth 2017-2028
6.3.2 Europe Pulmonary Arterial Hypertension (PAH) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth 2017-2028
6.4.2 Latin America Pulmonary Arterial Hypertension (PAH) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Actelion
7.1.1 Actelion Company Details
7.1.2 Actelion Business Overview
7.1.3 Actelion Pulmonary Arterial Hypertension (PAH) Introduction
7.1.4 Actelion Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022)
7.1.5 Actelion Recent Development
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Details
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Pulmonary Arterial Hypertension (PAH) Introduction
7.2.4 Gilead Sciences Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022)
7.2.5 Gilead Sciences Recent Development
7.3 United Therapeutics
7.3.1 United Therapeutics Company Details
7.3.2 United Therapeutics Business Overview
7.3.3 United Therapeutics Pulmonary Arterial Hypertension (PAH) Introduction
7.3.4 United Therapeutics Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022)
7.3.5 United Therapeutics Recent Development
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Details
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Introduction
7.4.4 GlaxoSmithKline Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022)
7.4.5 GlaxoSmithKline Recent Development
7.5 Pfizer
7.5.1 Pfizer Company Details
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Pulmonary Arterial Hypertension (PAH) Introduction
7.5.4 Pfizer Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022)
7.5.5 Pfizer Recent Development
7.6 Bayer
7.6.1 Bayer Company Details
7.6.2 Bayer Business Overview
7.6.3 Bayer Pulmonary Arterial Hypertension (PAH) Introduction
7.6.4 Bayer Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022)
7.6.5 Bayer Recent Development
7.7 Arena
7.7.1 Arena Company Details
7.7.2 Arena Business Overview
7.7.3 Arena Pulmonary Arterial Hypertension (PAH) Introduction
7.7.4 Arena Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022)
7.7.5 Arena Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Pulmonary Arterial Hypertension (PAH) Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Pulmonary Arterial Hypertension (PAH) Market Trends
Table 3. Pulmonary Arterial Hypertension (PAH) Market Drivers
Table 4. Pulmonary Arterial Hypertension (PAH) Market Challenges
Table 5. Pulmonary Arterial Hypertension (PAH) Market Restraints
Table 6. Global Pulmonary Arterial Hypertension (PAH) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Pulmonary Arterial Hypertension (PAH) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Pulmonary Arterial Hypertension (PAH) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Pulmonary Arterial Hypertension (PAH) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Pulmonary Arterial Hypertension (PAH) Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Pulmonary Arterial Hypertension (PAH) Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Pulmonary Arterial Hypertension (PAH) Revenue Share by Player, 2017-2022
Table 13. Global Pulmonary Arterial Hypertension (PAH) Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pulmonary Arterial Hypertension (PAH) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Arterial Hypertension (PAH) as of 2021)
Table 15. Top Players of Pulmonary Arterial Hypertension (PAH) in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Pulmonary Arterial Hypertension (PAH) Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Pulmonary Arterial Hypertension (PAH) Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Pulmonary Arterial Hypertension (PAH) Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Pulmonary Arterial Hypertension (PAH) Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Pulmonary Arterial Hypertension (PAH) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Pulmonary Arterial Hypertension (PAH) Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Pulmonary Arterial Hypertension (PAH) Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Pulmonary Arterial Hypertension (PAH) Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Pulmonary Arterial Hypertension (PAH) Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Pulmonary Arterial Hypertension (PAH) Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Pulmonary Arterial Hypertension (PAH) Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Pulmonary Arterial Hypertension (PAH) Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Actelion Company Details
Table 31. Actelion Business Overview
Table 32. Actelion Pulmonary Arterial Hypertension (PAH) Product
Table 33. Actelion Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022) & (US$ Million)
Table 34. Actelion Recent Development
Table 35. Gilead Sciences Company Details
Table 36. Gilead Sciences Business Overview
Table 37. Gilead Sciences Pulmonary Arterial Hypertension (PAH) Product
Table 38. Gilead Sciences Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022) & (US$ Million)
Table 39. Gilead Sciences Recent Development
Table 40. United Therapeutics Company Details
Table 41. United Therapeutics Business Overview
Table 42. United Therapeutics Pulmonary Arterial Hypertension (PAH) Product
Table 43. United Therapeutics Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022) & (US$ Million)
Table 44. United Therapeutics Recent Development
Table 45. GlaxoSmithKline Company Details
Table 46. GlaxoSmithKline Business Overview
Table 47. GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Product
Table 48. GlaxoSmithKline Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022) & (US$ Million)
Table 49. GlaxoSmithKline Recent Development
Table 50. Pfizer Company Details
Table 51. Pfizer Business Overview
Table 52. Pfizer Pulmonary Arterial Hypertension (PAH) Product
Table 53. Pfizer Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022) & (US$ Million)
Table 54. Pfizer Recent Development
Table 55. Bayer Company Details
Table 56. Bayer Business Overview
Table 57. Bayer Pulmonary Arterial Hypertension (PAH) Product
Table 58. Bayer Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022) & (US$ Million)
Table 59. Bayer Recent Development
Table 60. Arena Company Details
Table 61. Arena Business Overview
Table 62. Arena Pulmonary Arterial Hypertension (PAH) Product
Table 63. Arena Revenue in Pulmonary Arterial Hypertension (PAH) Business (2017-2022) & (US$ Million)
Table 64. Arena Recent Development
Table 65. Research Programs/Design for This Report
Table 66. Key Data Information from Secondary Sources
Table 67. Key Data Information from Primary Sources
List of Figures
Figure 1. Pulmonary Arterial Hypertension (PAH) Product Picture
Figure 2. Global Pulmonary Arterial Hypertension (PAH) Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Pulmonary Arterial Hypertension (PAH) Market Size 2017-2028 (US$ Million)
Figure 4. United States Pulmonary Arterial Hypertension (PAH) Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Pulmonary Arterial Hypertension (PAH) Market Size 2017-2028 (US$ Million)
Figure 6. United States Pulmonary Arterial Hypertension (PAH) Market Share in Global 2017-2028
Figure 7. Pulmonary Arterial Hypertension (PAH) Report Years Considered
Figure 8. Product Picture of Prostacyclin and Prostacyclin Analogs
Figure 9. Product Picture of SGC Stimulators
Figure 10. Product Picture of ERA
Figure 11. Product Picture of PDE-5
Figure 12. Global Pulmonary Arterial Hypertension (PAH) Market Share by Type in 2022 & 2028
Figure 13. Global Pulmonary Arterial Hypertension (PAH) Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Pulmonary Arterial Hypertension (PAH) Market Share by Type (2017-2028)
Figure 15. United States Pulmonary Arterial Hypertension (PAH) Market Share by Type in 2022 & 2028
Figure 16. United States Pulmonary Arterial Hypertension (PAH) Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Pulmonary Arterial Hypertension (PAH) Market Share by Type (2017-2028)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Global Pulmonary Arterial Hypertension (PAH) Market Share by Application in 2022 & 2028
Figure 21. Global Pulmonary Arterial Hypertension (PAH) Market Size by Application (2017-2028) & (US$ Million)
Figure 22. Global Pulmonary Arterial Hypertension (PAH) Market Share by Application (2017-2028)
Figure 23. United States Pulmonary Arterial Hypertension (PAH) Market Share by Application in 2022 & 2028
Figure 24. United States Pulmonary Arterial Hypertension (PAH) Market Size by Application (2017-2028) & (US$ Million)
Figure 25. United States Pulmonary Arterial Hypertension (PAH) Market Share by Application (2017-2028)
Figure 26. North America Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 27. U.S. Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Canada Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Europe Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. Germany Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. France Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. U.K. Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Italy Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Russia Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 36. China Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Japan Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. South Korea Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. India Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Australia Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Taiwan Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Indonesia Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Thailand Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Malaysia Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Philippines Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Latin America Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 47. Mexico Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Brazil Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Argentina Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate 2017-2028 (US$ Million)
Figure 51. Turkey Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. UAE Pulmonary Arterial Hypertension (PAH) Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Actelion Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2017-2022)
Figure 55. Gilead Sciences Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2017-2022)
Figure 56. United Therapeutics Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2017-2022)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2017-2022)
Figure 58. Pfizer Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2017-2022)
Figure 59. Bayer Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2017-2022)
Figure 60. Arena Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......

Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......

Global Amlodipine Besylate Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115

The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......

Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112

The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......

Captopril API - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100

The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Telmisartan - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107

The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......

Global Ambrisentan Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Ambrisentan Market Research Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs